Jalbout N, Karam A N, Karam E, Feghaly C, Khalaf H
Department of Anaesthesia, Saint George Hospital, Beirut, Lebanon.
J Med Liban. 1994;42(2):69-73.
In a randomized double-blind study, Midazolam (Dormicum) (7.5 mg) was compared with Promethazine (Phenergan) (25 mg), Droperidol (2.5 mg) and placebo as premedication for 98 pre-selected patients undergoing surgery. The anxiolytic effect of the above drugs was monitored by Beck's Anxiety Inventory. 83.3% of patients who received Midazolam had a decrease in their anxiety state compared to 55.6% for Promethazine, 12% for Droperidol and 25% for placebo. The study clearly proved that Midazolam is a better anxiolytic drug compared to Droperidol and Promethazine.
在一项随机双盲研究中,将咪达唑仑(多美康)(7.5毫克)与异丙嗪(非那根)(25毫克)、氟哌利多(2.5毫克)及安慰剂相比较,作为98例预先选定的接受手术患者的术前用药。上述药物的抗焦虑作用通过贝克焦虑量表进行监测。接受咪达唑仑的患者中83.3%的焦虑状态有所减轻,相比之下,接受异丙嗪的患者为55.6%,接受氟哌利多的患者为12%,接受安慰剂的患者为25%。该研究明确证明,与氟哌利多和异丙嗪相比,咪达唑仑是一种更好的抗焦虑药物。